Bone Marrow Disorders
Bone marrow disorders are a group of conditions in which the marrow, the tissue inside bones that produces blood cells, fails to make enough healthy red cells, white cells, or platelets, or produces them abnormally. They include aplastic anemia, a form of marrow failure, myelodysplastic syndromes (MDS), where blood cells form and mature abnormally, and other related marrow failure syndromes. Diagnosis requires bone marrow aspiration and biopsy alongside blood testing.
Understanding Bone Marrow Disorders
Bone marrow is the body's blood cell factory, continuously producing red cells, white cells, and platelets. A bone marrow disorder occurs when this production process fails, either because the marrow becomes underactive and produces too few cells of one or more types, as in aplastic anemia, or because it produces cells that are structurally or functionally abnormal, as in myelodysplastic syndromes. Both patterns result in low blood counts, called cytopenias, affecting one or more cell lines.
Causes of marrow disorders vary and include autoimmune processes that attack marrow cells, exposure to certain toxins, drugs, or radiation, viral infections, and inherited marrow failure syndromes; in many cases, no clear cause is identified. Myelodysplastic syndromes are of particular clinical interest because, in a proportion of cases, they can progress to acute myeloid leukemia over time, which is why ongoing monitoring and risk classification are an important part of management.
Because marrow disorders often present with vague symptoms like fatigue or are picked up through an abnormal routine blood count, an accurate diagnosis requires more than repeat blood tests. Bone marrow aspiration and biopsy, combined with cytogenetic and molecular testing, are needed to distinguish between the different marrow disorders and to determine risk category, which directly shapes the treatment approach.
Signs of Bone Marrow Disorders to watch for
When to see a haematologist
Abnormal blood counts affecting more than one cell line together, such as red cells, white cells, and platelets all being low, should be evaluated by a haematologist.
Fatigue combined with recurrent infections and unusual bruising occurring together needs prompt specialist assessment.
A complete blood count that remains abnormal despite treating common causes, such as iron deficiency, warrants further bone marrow evaluation.
Tests offered at the centre
Complete Blood Count and Peripheral Smear
Identifies which blood cell lines are affected and reveals characteristic cell changes that can point toward a specific marrow disorder.
Bone Marrow Aspiration and Biopsy
The essential test for diagnosing marrow disorders, directly assessing how the marrow is producing (or failing to produce) blood cells.
Cytogenetic and Molecular Testing
Identifies chromosomal and genetic changes within marrow cells, particularly important for risk stratification in myelodysplastic syndromes.
Flow Cytometry
Characterises abnormal cell populations within the marrow sample, supporting accurate classification of the disorder.
Treatment options
Your treatment plan is personalized to your diagnosis, subtype and overall health.
Supportive Care
Blood and platelet transfusions, growth factors, and infection prevention measures help manage symptoms and reduce risk while further treatment is planned.
Immunosuppressive Therapy
Used for immune-mediated marrow failure, such as certain cases of aplastic anemia, to reduce the immune attack on marrow cells and allow blood counts to recover.
Disease-Modifying Therapy for MDS
Treatment intensity is guided by the risk category of myelodysplastic syndrome, ranging from supportive monitoring to more active therapy.
Bone Marrow / Stem Cell Transplant
Considered for eligible patients, particularly those with higher-risk disease or severe marrow failure, as it offers the potential for durable disease control.
Regular Monitoring and Risk Reassessment
Ongoing blood counts and periodic marrow reassessment help track disease course and adjust treatment as needed over time.
Why choose AP Blood & Blood Cancer Centre
Accurately distinguishing between aplastic anemia, myelodysplastic syndromes, and other marrow disorders requires careful bone marrow evaluation and cytogenetic interpretation, which benefits from a single-specialty haematology setting focused specifically on this kind of diagnostic work.
Dr. Amarnadh Polisetty, MBBS, MD (General Medicine), DNB (Clinical Haematology), has over 7 years of clinical haematology experience and has been part of specialist transplant teams managing more than 500 bone marrow transplant patients, directly relevant to evaluating transplant candidacy for eligible patients with marrow failure. Management plans are personalized to the specific disorder and risk category identified.
Common questions about Bone Marrow Disorders
Medically reviewed by Dr. Amarnadh Polisetty, MD, DNB (Clinical Haematology)
Last reviewed on 1 July 2026
Unexplained low blood counts?
Persistently abnormal blood counts affecting more than one cell type should be evaluated by a clinical haematologist for a possible marrow disorder.